Back to ASCP Tumor Board Simulation: Immune-Related Adverse Events
This 90-minute online, interactive tumor board simulation on immune-related adverse events (irAEs) is designed to help pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team gain deeper scientific knowledge and skills in diagnosing, testing, and managing irAEs.
Case ideas were crowdsourced from ASCP members and include the following topics:
- irAEs in Special Populations
Additionally, there is a section on rare irAEs, including myocarditis and type 1 diabetes.
Throughout the tumor board simulation, you will answer questions designed to help you carefully consider the nuances of each case, building your knowledge and skills related to early detection and optimal management of irAEs. Additionally, the tumor board will reinforce the importance of communication and a team-based approach when irAEs occur, illustrating the contributions of different members of the cancer care team as they work together to optimize evidence-based clinical decision-making.
Upon completion of this activity, you should be able to:
- Discuss the importance of early detection and management of irAEs to assess response to I-O treatments
- Apply recommendations from the 2018 ASCO/NCCN guidelines, Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy, to the testing, reporting, and management of patients with irAEs
Jarushka Naidoo, MBBCh
Assistant Professor of Oncology and Attending Physician
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mizuki Nishino, MD
Associate Professor, Radiology, Harvard Medical School
Staff Radiologist, Radiology, Dana-Farber Cancer Institute
Staff Radiologist, Radiology, Brigham And Women's Hospital
Stuti G. Shroff, MBBS, PhD
Assistant Professor of Pathology, Harvard Medical School
Assistant Pathologist, Anatomic Pathology, Massachusetts General Hospital
The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The ASCP designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
These activities also meet Continuing Certification (CC) Part II Lifelong Learning and Self-Assessment Module (SAMs CME) requirements.
ASCP designates these enduring material for a maximum of 1.5 CMLE credit. These activities meet CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.
Funded by an independent educational grants from Bristol-Myers Squibb.